Ng George K 4/A

What Happened

• CEO Ng George K reported an open-market or private purchase (Form 4 code "P") of 2,136 shares of Processa Pharmaceuticals (PCSA) on 2026-03-31. The shares were acquired at $2.54 per share, for a total transaction value of about $5,415. This is a purchase (insider buy), though the dollar amount is modest.

Key Details

• Transaction date and price: 2026-03-31 at $2.54 per share (2,136 shares; ~$5,415).
• Transaction type: Purchase (Form 4 code "P" — open market or private purchase).
• Filing: Amended Form 4 filed 2026-04-30 (the amendment was filed ~30 days after the transaction).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other footnotes were provided in the supplied data.

Context

• Insider purchases can be interpreted as a vote of confidence, but this particular buy is small in dollar terms and may be routine. The filing was amended and submitted well after the transaction date, which reduces timeliness for investors relying on immediate insider-disclosure signals. This was a straight purchase—not an option exercise, gift, or tax withholding event.